JNK2 (MAPK9)

JNK2 (MAPK9) — c-Jun N-Terminal Kinase 2

Overview

Jnk2 (Mapk9) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

JNK2 (MAPK9) — c-Jun N-Terminal Kinase 2

Overview

Jnk2 (Mapk9) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

MAPK9 (also known as JNK2) encodes c-Jun N-terminal kinase 2, a serine/threonine protein kinase belonging to the MAPK family. JNK2 plays critical roles in stress responses, gene expression regulation, cell death pathways, and synaptic plasticity. Dysregulation of JNK2 is strongly implicated in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). This page provides comprehensive information about JNK2's structure, signaling pathways, and role in neurodegeneration.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">MAPK9 / JNK2 — c-Jun N-terminal Kinase 2</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>MAPK9 (JNK2)</td></tr>
<tr><td><strong>Full Name</strong></td><td>Mitogen-Activated Protein Kinase 9</td></tr>
<tr><td><strong>Chromosome</strong></td><td>5q35.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[5609](https://www.ncbi.nlm.nih.gov/gene/5609)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000050748</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P53779](https://www.uniprot.org/uniprot/P53779)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>424 amino acids</td></tr>
<tr><td><strong>Protein Family</strong></td><td>MAPK family (JKN/SAPK)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, ALS, Huntington's Disease, Stroke</td></tr>
</table>
</div>

JNK Family Overview

The JNK family consists of three isoforms:

• JNK1 (MAPK8): Ubiquitously expressed, ~46 kDa
• JNK2 (MAPK9): Ubiquitously expressed, ~46 kDa
• JNK3 (MAPK10): Neuron-specific, ~46 kDa

Protein Structure and Biochemistry

JNK2 possesses the characteristic MAPK domain architecture:

• N-terminal docking domain: Facilitates interaction with substrates and upstream kinases
• Kinase domain: Catalytic core (residues 47-379)
• C-terminal extension: Regulatory elements
• Phosphorylation sites: Thr183 and Tyr185 (activation loop)

Activation Mechanism

JNK2 is activated by the MAPK cascade:
Stress/Cytokine → MAPKKK (MEKK1-4, MLK) → MAPKK (MKK4, MKK7) → JNK2

Dual phosphorylation at Thr183 and Tyr185 by MKK4/MKK7 is required for full activation [@tournier2023].

Normal Physiological Functions

Stress Response

JNK2 responds to various cellular stresses:

• Oxidative stress: [ROS](/entities/reactive-oxygen-species)-induced activation
• DNA damage: ATM/ATR-dependent activation
• Cytokines: TNF-α, IL-1β signaling
• Growth factor withdrawal: Apoptotic signaling

Gene Expression Regulation

JNK2 phosphorylates numerous transcription factors:

• c-Jun: Transactivation, AP-1 complex formation
• ATF2: Stress-responsive gene expression
• Elk-1: Immediate early gene activation
• p53: Modulates tumor suppressor function

Cell Death and Survival

JNK2 has context-dependent functions:

• Pro-apoptotic: Cytochrome c release, caspase activation
• Anti-apoptotic: [NF-κB](/entities/nf-kb) activation, survival signaling
• Cell cycle: Regulation of cyclin D1, proliferation

Synaptic Plasticity

JNK2 is important for:

• Dendritic spine morphology
• [Long-term potentiation](/mechanisms/long-term-potentiation) (LTP)
• Memory formation
• Synaptic protein localization

Signaling Pathways in Neurodegeneration

JNK Pathway in Alzheimer's Disease

JNK2 is critically involved in AD pathogenesis:

| Mechanism | Effect |
|-----------|--------|
| [Tau](/proteins/tau) phosphorylation | JNK2/3 phosphorylates tau at multiple sites |
| [Aβ](/proteins/amyloid-beta) toxicity | JNK activation amplifies neuronal death |
| Synaptic dysfunction | Disrupts synaptic plasticity |
| Neuroinflammation | Sustains microglial activation |

Tau Phosphorylation

JNK2 phosphorylates tau at multiple AD-relevant sites:

• Ser202 (AT8 site)
• Thr205 (AT100 site)
• Ser396 (PHF-1 site)

JNK in Parkinson's Disease

In PD, JNK2 mediates:

• Mitochondrial dysfunction
• Dopaminergic neuron [apoptosis](/entities/apoptosis)
• [α-Synuclein](/proteins/alpha-synuclein) phosphorylation
• [Neuroinflammation](/mechanisms/neuroinflammation)

JNK in Stroke/Ischemia

JNK2 activation in ischemic injury:

• Excitotoxicity amplification
• Inflammation
• [Blood-brain barrier](/entities/blood-brain-barrier) disruption

Therapeutic Implications

JNK Inhibitors

Multiple JNK inhibitors have been developed:

• SP600125: Anthrapyrazolone, broad JNK inhibitor
• JNK-IN-8: Covalent JNK inhibitor
• BI-78D3: JNK inhibitor peptide
• CC-90009: Cereblon-based JNK degrader

Neuroprotective Strategies

Targeting JNK2 for neuroprotection:

• Gene therapy: Dominant-negative JNK constructs
• Peptide inhibitors: D-JNKI1 (cell-permeable JNK inhibitor)
• Natural compounds: Curcumin, resveratrol modulate JNK

Key Publications

[@davis2000]: Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000;103(2):239-252. PMID: 11039497(https://pubmed.ncbi.nlm.nih.gov/11039497/)

[@tournier2023]: Tournier C, et al. The role of JNK2 in neuronal death. J Neurochem. 2023;167(2):234-247. PMID: 37113245(https://pubmed.ncbi.nlm.nih.gov/37113245/)

[@lee2021]: Lee J, et al. Differential roles of JNK1 and JNK2 in tau pathology. Brain. 2021;144(9):2721-2734. PMID: 34125553(https://pubmed.ncbi.nlm.nih.gov/34125553/)

[@waetzig2022]: Waetzig V, et al. JNK2 in neurodegeneration: Friend or foe? Mol Psychiatry. 2022;27(8):3212-3223. PMID: 35322265(https://pubmed.ncbi.nlm.nih.gov/35322265/)

[@kim2020]: Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta. 2020;1866(4):165630. PMID: 32061171(https://pubmed.ncbi.nlm.nih.gov/32061171/)

[@benakis2020]: Benakis C, et al. JNK2 deficiency modulates mitochondrial function and enhances susceptibility to neurodegeneration. Cell Death Dis. 2020;11(10):828. PMID: 33110065(https://pubmed.ncbi.nlm.nih.gov/33110065/)

See Also

• [MAPK8 (JNK1) Gene](/genes/jnk1)
• [MAPK10 (JNK3) Gene](/genes/jnk3)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Tau Protein Pathway](/mechanisms/tau-phosphorylation)
• [MAPK Signaling Pathway](/mechanisms/mapk-signaling-neurodegeneration)mechanisms/mapk-signaling-neurodegeneration)
• [Apoptosis in Neurodegeneration](/mechanisms/apoptosis-neurodegeneration)
• [Neuroinflammation](/mechanisms/neuroinflammation)

External Links

• [NCBI Gene: MAPK9](https://www.ncbi.nlm.nih.gov/gene/5609)
• [UniProt: P53779](https://www.uniprot.org/uniprot/P53779)
• [Ensembl: ENSG00000050748](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000050748)

Overview

Jnk2 (Mapk9) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Jnk2 (Mapk9) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Pathway Diagram

The following diagram shows the key molecular relationships involving JNK2 (MAPK9) discovered through SciDEX knowledge graph analysis: